Table 1 Recipient characteristics at the time of allogeneic hematopoietic stem cell transplantation
Allogenic HSCT Recipients (n = 19) | |
|---|---|
Age at HSCT, years | |
Median [IQR] | 31.3 (17.1–38.7] |
Sex, % male | 47.40% |
Indication for HSCT | |
CML | 31.6% (6) |
ALL | 21.1% (4) |
AML | 15.8% (3) |
Other | 31.6% (6) |
Stem cell donors | |
Matched related | 84.2% (16) |
Matched unrelated | 10.5% (2) |
Haplo-identical | 5.3% (1) |
Myeloablative conditioning1 | |
TBI conditioning | 73.3% (11) |
Non-TBI conditioning | 26.7% (4) |
Presence of extra-pulmonary GVHD | |
Skin | 63.2% (12) |
Eyes | 47.4% (9) |
Oral | 47.4% (9) |
Liver or GI tract | 21.1% (4) |
Time from HSCT to LTx | |
Median [IQR] | 10.2 [2.9–14.4] |
Lung explant pathological diagnosis | |
Bronchiolitis obliterans | 78.9% (15) |
Pleuro-parenchymal fibro-elastosis | 21.1% (4) |